EZH2 and gastric cancer: identified SET and MYND domain-containing protein 3 (SMYD3) as the methyltransferase of EZH2 at K421 residue which accelerates EZH2 ubiquitin proteasome degradation to promote M2 polarization in gastric cancer (72).